Evidence map›Paper›PMID 34451818›Full record

ReviewPharmaceuticals (Basel, Switzerland)2021

Primary and Metastatic Brain Tumours Assessed with the Brain and Torso [

Agata Pietrzak, Andrzej Marszałek, Tomasz Piotrowski, Adrianna Medak, Katarzyna Pietrasz, Julia Wojtowicz, Hubert Szweda, Krzysztof Matuszewski, Witold Cholewiński

Abstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Comparative Insights intoMolecular imaging and radionuclide therapy · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Agata PietrzakElectroradiology Department, Poznan University of Medical Sciences, 61-866 Poznan, Poland.ORCID 0000-0002-0476-5655
Andrzej MarszałekOncologic Pathology and Prophylaxis Department, Poznan University of Medical Sciences and Greater Poland Cancer Center, 61-866 Poznan, Poland.
Tomasz PiotrowskiElectroradiology Department, Poznan University of Medical Sciences, 61-866 Poznan, Poland.
Adrianna MedakElectroradiology Department, Poznan University of Medical Sciences, 61-866 Poznan, Poland.
Katarzyna PietraszNuclear Medicine Department, Greater Poland Cancer Centre, 61-866 Poznan, Poland.
Julia WojtowiczMedical Faculty, Lodz Medical University, 90-647 Lodz, Poland.
Hubert SzwedaMedical Physics Department, Greater Poland Cancer Centre, 61-866 Poznan, Poland.
Krzysztof MatuszewskiMedical Physics Department, Greater Poland Cancer Centre, 61-866 Poznan, Poland.
Witold CholewińskiElectroradiology Department, Poznan University of Medical Sciences, 61-866 Poznan, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

According to the international societies' recommendations, the 2-deoxy-2-[

Indexed as

18F-fluorodeoxyglucosebrain tumouroncologypositron emission tomography

Identifiers

PMID34451818
PMCPMC8401235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.